ACAD
41.98
+0.41
+0.99%
AEMD
6.6
-0.15
-2.22%
APRI
1.82
-0.05
-2.67%
ARNA
4.48
-0.04
-0.88%
ATEC
1.37
+0.01
+0.74%
CNAT
4.92
-0.1
-1.99%
CRXM
0.285
-0.035
-10.938%
CYTX
0.505
-0.025
-4.681%
DXCM
81.07
+1.36
+1.71%
GNMK
9.1
+0.13
+1.45%
HALO
21.94
-0.84
-3.69%
ILMN
221.77
+1.26
+0.57%
INNV
0.14
+0.02
+16.5833%
INO
7.65
-0.22
-2.80%
ISCO
0.048
+0.00
+0.8421%
ISIS
55.36
-0.07
-0.13%
LGND
97.65
-1.28
-1.29%
LPTN
0.261
+0.005
+1.9148%
MBVX
2.35
-0.24
-9.27%
MEIP
1.75
+0.01
+0.57%
MNOV
4.03
+0.09
+2.28%
MRTX
31.68
-0.17
-0.53%
MSTX
0.459
-0.003
-0.5845%
NBIX
48.44
+0.12
+0.25%
NUVA
48.01
+0.52
+1.09%
ONCS
6.02
-0.1
-1.63%
ONVO
3.8
+0.07
+1.88%
OREX
4.71
-0.06
-1.26%
OTIC
23
+0.94
+4.26%
QDEL
22.68
-0.12
-0.53%
RCPT
197.73
-0.52
-0.26%
RGLS
10.54
+0.22
+2.13%
RMD
56.63
+1.25
+2.26%
SCIE
0.012
-0.002
-17.241%
SPHS
0.78
-0.02
-2.50%
SRNE
17.26
-0.03
-0.17%
TROV
9.57
-0.53
-5.25%
VICL
0.7
0.00
0.00%
ZGNX
13.35
+0.32
+2.46%
ACAD
41.98
+0.41
+0.99%
AEMD
6.6
-0.15
-2.22%
APRI
1.82
-0.05
-2.67%
ARNA
4.48
-0.04
-0.88%
ATEC
1.37
+0.01
+0.74%
CNAT
4.92
-0.1
-1.99%
CRXM
0.285
-0.035
-10.938%
CYTX
0.505
-0.025
-4.681%
DXCM
81.07
+1.36
+1.71%
GNMK
9.1
+0.13
+1.45%
HALO
21.94
-0.84
-3.69%
ILMN
221.77
+1.26
+0.57%
INNV
0.14
+0.02
+16.5833%
INO
7.65
-0.22
-2.80%
ISCO
0.048
+0.00
+0.8421%
ISIS
55.36
-0.07
-0.13%
LGND
97.65
-1.28
-1.29%
LPTN
0.261
+0.005
+1.9148%
MBVX
2.35
-0.24
-9.27%
MEIP
1.75
+0.01
+0.57%
MNOV
4.03
+0.09
+2.28%
MRTX
31.68
-0.17
-0.53%
MSTX
0.459
-0.003
-0.5845%
NBIX
48.44
+0.12
+0.25%
NUVA
48.01
+0.52
+1.09%
ONCS
6.02
-0.1
-1.63%
ONVO
3.8
+0.07
+1.88%
OREX
4.71
-0.06
-1.26%
OTIC
23
+0.94
+4.26%
QDEL
22.68
-0.12
-0.53%
RCPT
197.73
-0.52
-0.26%
RGLS
10.54
+0.22
+2.13%
RMD
56.63
+1.25
+2.26%
SCIE
0.012
-0.002
-17.241%
SPHS
0.78
-0.02
-2.50%
SRNE
17.26
-0.03
-0.17%
TROV
9.57
-0.53
-5.25%
VICL
0.7
0.00
0.00%
ZGNX
13.35
+0.32
+2.46%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …